cerrar
Tagged with Novartis

Brexit: A Serious Threat to Patients
As the UK extracts itself from the European Union, key figures from the country's life sciences sector are split on the implications of Brexit for…

Cristina Campos – CPO Head and Country President, Novartis…
Cristina Campos is well known on the Portuguese pharmaceutical circuit, directing the affiliate of market leader, Novartis, and holding a position as…

Haseeb Ahmad – Country President, Novartis UK
Only 14 months in position, UK country president at Novartis, Haseeb Ahmad, shares insights into the company’s new strategy. He further analyses how…

Top 20 Pharma Companies in Ecuador Ranking
The top 20 pharma companies in Ecuador in 2017, ranked by value, for both the retail and public markets. Argentinian firm Roemmers leads the way in…

Top 20 Pharma Companies in Lithuania Ranking
The Top 20 pharma companies in Lithuania by value for 2017. J&J leads the way with a value of around EUR 35 million and market share of 6.3%…

Interview: Jawed Zia – Country President, Novartis India
Think global, act local! This is the Novartis business approach in India. A great believer in stakeholder collaboration, Jawed Zia, country president…

Top 10 Pharma Companies in Canada Ranking (2016)
The top 10 pharmaceutical companies in Canada for 2016 in terms of total sales and market share. Johnson & Johnson leads the way with USD 2.93…

India: Still a Land of Opportunity for MNCs
For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India still stands as a land of…

Luciano Marques – President, Alcon, Brazil
Luciano Marques, president of Alcon Brazil, provides insights into recent investments and innovative initiatives aimed at strengthening Alcon’s…

Interview: Predrag Bogavac – Country Head, OGM Serbia and…
Predrag Bogavac, now Country Head, OGM Serbia and Montenegro, a.i. Oncology General Manager Bulgaria and Macedonia at Novartis, shares the highlights…

MNCs’ Healthcare Access Initiatives in India
With the Indian public healthcare apparatus straining at the seams to provide affordable access to treatments to the country’s vast population, two…

Bruno Strigini – CEO, Novartis Oncology
In an exclusive interview, Bruno Strigini, global CEO of Novartis Oncology, discusses the logic of the company’s separate oncology business unit,…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here